Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jacobson Pharma Corporation Limited (HK:2633)
HKEX:2633
Holding HK:2633?
Track your performance easily
2633 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$0.54 - HK$0.82
Previous CloseHK$0.8
Volume896.85K
Average Volume (3M)766.68K
Market Cap
HK$1.52B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)6.4
Beta0.45
Next Earnings
Jul 01, 2025EPS EstimateN/A
Next Dividend Ex-Date
Feb 25, 2025Dividend Yield6.96%
Share Statistics
EPS (TTM)0.12
Shares OutstandingN/A
10 Day Avg. Volume1,663,722
30 Day Avg. Volume766,681
Standard Deviation0.11
R-Squared0.16
Alpha0.00657
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Jacobson Pharma Corporation Limited News
PremiumCompany Announcements
Jacobson Pharma Sees Strong Growth in 2024 Interim Results
PremiumCompany Announcements
Jacobson Pharma Declares Interim Dividend for 2024
PremiumCompany Announcements
Jacobson Pharma’s Strategic Share Transaction Unveiled
PremiumCompany Announcements
Jacobson Pharma to Announce Interim Results and Dividend
PremiumCompany Announcements
Jacobson Pharma Expects Significant Profit GrowthPremiumCompany Announcements
Jacobson Pharma Wins Full Investor Backing at AGM
PremiumCompany Announcements
Jacobson Pharma Announces Upcoming AGMPremiumCompany Announcements
Jacobson Pharma Announces Impressive Annual GrowthOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.06% Mutual Funds
― Other Institutional Investors
99.94% Public Companies and
Individual Investors
2633 FAQ
What was Jacobson Pharma Corporation Limited’s price range in the past 12 months?
Jacobson Pharma Corporation Limited lowest stock price was HK$0.54 and its highest was HK$0.82 in the past 12 months.
What is Jacobson Pharma Corporation Limited’s market cap?
Currently, no data Available
When is Jacobson Pharma Corporation Limited’s upcoming earnings report date?
Jacobson Pharma Corporation Limited’s upcoming earnings report date is Jul 01, 2025 which is in 220 days.
How were Jacobson Pharma Corporation Limited’s earnings last quarter?
Jacobson Pharma Corporation Limited released its earnings results on Nov 21, 2024. The company reported HK$0.071 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.071.
Is Jacobson Pharma Corporation Limited overvalued?
According to Wall Street analysts Jacobson Pharma Corporation Limited’s price is currently Overvalued.
Does Jacobson Pharma Corporation Limited pay dividends?
Jacobson Pharma Corporation Limited pays a Annually dividend of HK$0.04 which represents an annual dividend yield of 6.96%. See more information on Jacobson Pharma Corporation Limited dividends here
What is Jacobson Pharma Corporation Limited’s EPS estimate?
Jacobson Pharma Corporation Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jacobson Pharma Corporation Limited have?
Jacobson Pharma Corporation Limited has 2,000,221,000 shares outstanding.
What happened to Jacobson Pharma Corporation Limited’s price movement after its last earnings report?
Jacobson Pharma Corporation Limited reported an EPS of HK$0.071 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.266%.
Which hedge fund is a major shareholder of Jacobson Pharma Corporation Limited?
Currently, no hedge funds are holding shares in HK:2633
---
Jacobson Pharma Corporation Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
39.13%
12-Months-Change
Fundamentals
Return on Equity
8.23%
Trailing 12-Months
Asset Growth
-35.19%
Trailing 12-Months
Technical Analysis
---